Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease.
Fallingborg J, Pedersen P, Jacobsen BA. Fallingborg J, et al. Dig Dis Sci. 1998 Apr;43(4):702-5. doi: 10.1023/a:1018893409596. Dig Dis Sci. 1998. PMID: 9558022
Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
Larsen L, Drewes AM, Broberg MCH, Fallingborg J, Jacobsen BA, Jensen TB, Jess T. Larsen L, et al. Among authors: fallingborg j. Inflamm Bowel Dis. 2018 Jan 18;24(2):433-439. doi: 10.1093/ibd/izx038. Inflamm Bowel Dis. 2018. PMID: 29361095
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
Julsgaard M, Hvas CL, Gearry RB, Vestergaard T, Fallingborg J, Svenningsen L, Kjeldsen J, Sparrow MP, Wildt S, Kelsen J, Bell SJ. Julsgaard M, et al. Among authors: fallingborg j. Inflamm Bowel Dis. 2017 Jul;23(7):1240-1246. doi: 10.1097/MIB.0000000000001136. Inflamm Bowel Dis. 2017. PMID: 28498159
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Fallingborg J, Christensen LA, Pedersen G, Kjeldsen J, Jacobsen BA, Oxholm AS, Kjellberg J, Bendtzen K, Ainsworth MA. Steenholdt C, et al. Among authors: fallingborg j. Dig Dis Sci. 2015 Sep;60(9):2762-70. doi: 10.1007/s10620-015-3581-4. Epub 2015 Feb 12. Dig Dis Sci. 2015. PMID: 25673037 Clinical Trial.
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.
Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Fallingborg J, Christensen LA, Pedersen G, Kjeldsen J, Jacobsen BA, Oxholm AS, Kjellberg J, Bendtzen K, Ainsworth MA. Steenholdt C, et al. Among authors: fallingborg j. Gut. 2014 Jun;63(6):919-27. doi: 10.1136/gutjnl-2013-305279. Epub 2013 Jul 22. Gut. 2014. PMID: 23878167 Clinical Trial.
Low-dose cyclosporin for Crohn's disease: implications for clinical trials.
Brynskov J, Binder V, Riis P, Lauritsen K, Schaffalitzky de Muckadell O, Freund L, Fallingborg J, Nørby Rasmussen S, Matzen P, Krag E, et al. Brynskov J, et al. Among authors: fallingborg j. Aliment Pharmacol Ther. 1989 Apr;3(2):135-42. doi: 10.1111/j.1365-2036.1989.tb00199.x. Aliment Pharmacol Ther. 1989. PMID: 2491464
Gastrointestinal pH and transit times in healthy subjects with ileostomy.
Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH, Rasmussen SN. Fallingborg J, et al. Aliment Pharmacol Ther. 1990 Jun;4(3):247-53. doi: 10.1111/j.1365-2036.1990.tb00469.x. Aliment Pharmacol Ther. 1990. PMID: 2104088
Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.
Christensen LA, Fallingborg J, Jacobsen BA, Abildgaard K, Rasmussen HH, Rasmussen SN, Hansen SH. Christensen LA, et al. Among authors: fallingborg j. Dig Dis Sci. 1993 Oct;38(10):1831-6. doi: 10.1007/BF01296106. Dig Dis Sci. 1993. PMID: 8104772
99mTc-sucralfate scintigraphy in inflammatory bowel disease.
Mortensen PB, Lech Y, Møller-Petersen J, Vilien M, Fallingborg J, Ekelund S. Mortensen PB, et al. Among authors: fallingborg j. Scand J Gastroenterol. 1989 Nov;24(9):1126-8. doi: 10.3109/00365528909089266. Scand J Gastroenterol. 1989. PMID: 2595274
pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.
Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH. Fallingborg J, et al. Aliment Pharmacol Ther. 1989 Dec;3(6):605-13. doi: 10.1111/j.1365-2036.1989.tb00254.x. Aliment Pharmacol Ther. 1989. PMID: 2518873
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback